Left ventricular hypertrophy after hypertensive pregnancy disorders

Heart

Volumn 101, Issue 19, 2015, Pages 1584-1590

  Scantlebury, Dawn C ^a   Kane, Garvan C ^a   Wiste, Heather J ^a   Bailey, Kent R ^a   Turner, Stephen T ^a   Arnett, Donna K ^b   Devereux, Richard B ^c   Mosley, Thomas H ^d   Hunt, Steven C ^e   Weder, Alan B ^f   Rodriguez, Beatriz ^g   Boerwinkle, Eric ^h   Weissgerber, Tracey L ^a   Garovic, Vesna D ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF MISSISSIPPI   (United States)

^e UNIVERSITY OF UTAH   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g UNIVERSITY OF HAWAII   (United States)

^h UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; EDUCATIONAL STATUS; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PARITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; WOMEN'S HEALTH; AGED; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; DIASTOLE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HYPERTENSION, PREGNANCY-INDUCED; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; MULTICENTER STUDY; ODDS RATIO; PATHOPHYSIOLOGY; PREGNANCY; PREVALENCE; STATISTICAL MODEL; SYSTOLE; TIME; UNITED STATES;

ADULT; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIASTOLE; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; HYPERTROPHY, LEFT VENTRICULAR; LINEAR MODELS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; PREGNANCY; PREVALENCE; RISK FACTORS; SYSTOLE; TIME FACTORS; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84941641613     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-308098     Document Type: Article

References (31)

1. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6.
2. Haider AW, Larson MG, Benjamin EJ, et al. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 1998;32:1454-9.
3. Krumholz HM, Larson M, Levy D. Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol 1993;72:310-3.
4. Bella JN, Palmieri V, Roman MJ, et al. Gender differences in left ventricular systolic function in American Indians (from the Strong Heart Study). Am J Cardiol 2006;98:834-7.
5. Scantlebury DC, Borlaug BA. Why are women more likely than men to develop heart failure with preserved ejection fraction? Curr Opin Cardiol 2011;26:562-8.
6. Mannisto T, Mendola P, Vaarasmaki M, et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation 2013;127:681-90.
7. Craici I, Wagner S, Garovic VD. Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? Ther Adv Cardiovasc Dis 2008;2:249-59.
8. McDonald SD, Malinowski A, Zhou Q, et al. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008;156:918-30.
9. Melchiorre K, Sutherland GR, Baltabaeva A, et al. Maternal cardiac dysfunction and remodeling in women with preeclampsia at term. Hypertension 2011;57:85-93.
10. Bamfo JE, Kametas NA, Chambers JB, et al. Maternal cardiac function in normotensive and pre-eclamptic intrauterine growth restriction. Ultrasound Obstet Gynecol 2008;32:682-6.
11. Tihtonen KM, Koobi T, Vuolteenaho O, et al. Uotila JT. Natriuretic peptides and hemodynamics in preeclampsia. Am J Obstet Gynecol 2007;196:328.e1-7.
12. Melchiorre K, Sutherland GR, Liberati M, et al. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension 2011;58:709-15.
13. Ray JG, Schull MJ, Kingdom JC, et al. Heart failure and dysrhythmias after maternal placental syndromes: HAD MPS Study. Heart 2012;98:1136-41.
14. Program (FBPP). Multi-center genetic study of hypertension: the Family Blood Pressure Program (FBPP). Hypertension 2002;39:3-9.
15. Province MA, Boerwinkle E, Chakravarti A, et al. Lack of association of the angiotensinogen-6 polymorphism with blood pressure levels in the comprehensive NHLBI Family Blood Pressure Program. National Heart, Lung and Blood Institute. J Hypertens 2000;18:867-76.
16. Bella JN, Palmieri V, Kitzman DW, et al. Gender difference in diastolic function in hypertension (the HyperGEN study). Am J Cardiol 2002;89:1052-6.
17. Palmieri V, Bella JN, Arnett DK, et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation 2001;103:102-7.
18. Bella JN, Palmieri V, Liu JE, et al. Relationship between left ventricular diastolic relaxation and systolic function in hypertension: The Hypertension Genetic Epidemiology Network (HyperGEN) Study. Hypertension 2001;38:424-8.
19. Diehl CL, Brost BC, Hogan MC, et al. Preeclampsia as a risk factor for cardiovascular disease later in life: validation of a preeclampsia questionnaire. Am J Obstet Gynecol 2008;198:e11-13.
20. Sahn DJ, De Maria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
21. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
22. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
23. Teichholz LE, Kreulen T, Herman MV, et al. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976;37:7-11.
24. Levy D, Anderson KM, Savage DD, et al. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 1988;108:7-13.
25. Valensise H, Vasapollo B, Gagliardi G, et al. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 2008;52:873-80.
26. Ghossein-Doha C, Peeters L, Van Heijster S, et al. Hypertension after preeclampsia is preceded by changes in cardiac structure and function. Hypertension 2013;62:382-90.
27. De Simone G, Devereux RB, Chinali M, et al. Left ventricular mass and incident hypertension in individuals with initial optimal blood pressure: the Strong Heart Study. J Hypertens 2008;26:1868-74.
28. Ghossein-Doha C, Van Kuijk SM, Spaanderman ME, et al. Age-related alterations in cardiac geometry in formerly preeclamptic women and healthy parous controls: an explorative study. Reprod Sci 2013;20:39-44.
29. Strobl I, Windbichler G, Strasak A, et al. Left ventricular function many years after recovery from pre-eclampsia. Bjog 2011;118:76-83.
30. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014;129:e28-292.
31. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the american heart association. Circulation 2011;123:1243-62.